6Referral of designated tests by 1 pathology practitioner to another

6 Referral of designated tests by 1 pathology practitioner to another

(1) In this rule:

designated test means a pathology test relating to a patient episode that is a test of a kind mentioned in item 65150, 65175, 66650, 66695, 66711, 66722, 66785, 66800, 66812, 66819, 66825, 69384, 69494, 71089, 71153 or 77165.

(2) This rule applies if 1 or more designated tests are referred by a referring APP to a receiving APP in another approved pathology authority.

(3) If a referring APP has rendered 1 or more designated tests:

(a) the amount mentioned in item 65150, 65153, 65175, 65176, 65177, 65178, 66650, 66695, 66698, 66701, 66704, 66707, 66711, 66722, 66725, 66728, 66731, 66785, 66800, 66803, 66812, 66819, 66825, 69384, 69387, 69390, 69393, 69396, 69494, 69495, 71089, 71091, 71153, 71155, 71157, 77165, 71166 or 71167 (as the case may be) is payable for each designated test rendered by the referring APP; and

(b) subject to subrule (5), the amount mentioned in item 65158, 65181, 66652, 66697, 66715, 66724, 66790, 66805, 66817, 66821, 66827, 69401, 69498, 71092, 71156 or 71170 (as the case may be) is payable for each designated test rendered by the receiving APP.

(4) If a referring APP has not rendered a designated test:

(a) for the first designated test that is rendered by the receiving APP — the amount mentioned in item 65157 65180 66651 66696, 66714, 66723, 66789, 66804, 66816, 66820, 66826, 69400, 69497, 71090, 71154 or 71169 (as the case may be) is payable; and

(b) for each subsequent designated test (if any) that is rendered by the receiving APP — subject to subrule (6), the amount mentioned in item 65158, 65181, 66652, 66697, 66715, 66724, 66790, 66805, 66817, 66821, 66827, 69401, 69498, 71092, 71156 or 71170 (as the case may be) is payable for each test rendered.

(5) For paragraph (3) (b), the maximum number of designated tests for which the fee mentioned in the relevant item is payable is as follows:

(a) for item 66652, 66715, 66790, 66817, 66821 or 66827 —

Image unavailable in extracted text

(b) for item 65158, 66805, 69498 or 71092 —

Image unavailable in extracted text

(c) for item 71156 or 71170 —

Image unavailable in extracted text

(d) for item 65181 or 66724 —

Image unavailable in extracted text

(e) for item 66697 or 69401 —

Image unavailable in extracted text

where:

X is the number of designated tests rendered by a referring APP.

(6) For paragraph (4) (b), the maximum number of designated tests for which the fee mentioned in the relevant item is payable is as follows:

(a) for item 66652, 66715, 66790, 66817, 66821 or 66827 — 1;

(b) for item 65158, 66805, 69498 or 71092 — 2;

(c) for item 71156 or 71170 — 3;

(d) for item 65181 or 66724 — 4;

(e) for item 66697 or 69401 — 5.

(7) Items in Group P10 (Patient episode initiation) do not apply to a receiving APP in subrule (2).